<PubmedArticle>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26261728</PMID>
<DateCompleted>
<Year>2015</Year>
<Month>08</Month>
<Day>11</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">2078-6891</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>6</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of gastrointestinal oncology</Title>
<ISOAbbreviation>J Gastrointest Oncol</ISOAbbreviation>
</Journal>
<ArticleTitle>Neoadjuvant therapy for localized pancreatic cancer: guiding principles.</ArticleTitle>
<Pagination>
<MedlinePgn>418-29</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3978/j.issn.2078-6891.2015.053</ELocationID>
<Abstract>
<AbstractText>The management of localized pancreatic cancer (PC) remains controversial. Historically, patients with localized disease have been treated with surgery followed by adjuvant therapy (surgery-first approach) under the assumption that surgical resection is necessary, even if not sufficient for cure. However, a surgery-first approach is associated with a median overall survival of only 22-24 months, suggesting that a large proportion of patients with localized PC have clinically occult metastatic disease. As a result, adjuvant therapy has been recommended for all patients with localized PC, but in actuality, it is often not received due to the high rates of perioperative complications associated with pancreatic resections. Recognizing that surgery may be necessary but usually not sufficient for cure, there has been growing interest in neoadjuvant treatment sequencing, which benefits patients with both localized and metastatic PC by ensuring the delivery of oncologic therapies which are commensurate with the stage of disease. For patients who have clinically occult metastatic disease, neoadjuvant therapy allows for the early delivery of systemic therapy and avoids the morbidity and mortality of a surgical resection which would provide no oncologic benefit. For patients with truly localized disease, neoadjuvant therapy ensures the delivery of all components of the multimodality treatment. This review details the rationale for a neoadjuvant approach to localized PC and provides specific recommendations for both pretreatment staging and treatment sequencing for patients with resectable and borderline resectable (BLR) disease. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Fathi</LastName>
<ForeName>Amir</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Surgery, 2 Department of Medicine, 3 Department of Radiation Oncology, 4 Department of Radiology, Pancreatic Cancer Program, The Medical College of Wisconsin, Milwaukee, WI 53226, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Christians</LastName>
<ForeName>Kathleen K</ForeName>
<Initials>KK</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Surgery, 2 Department of Medicine, 3 Department of Radiation Oncology, 4 Department of Radiology, Pancreatic Cancer Program, The Medical College of Wisconsin, Milwaukee, WI 53226, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>George</LastName>
<ForeName>Ben</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Surgery, 2 Department of Medicine, 3 Department of Radiation Oncology, 4 Department of Radiology, Pancreatic Cancer Program, The Medical College of Wisconsin, Milwaukee, WI 53226, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ritch</LastName>
<ForeName>Paul S</ForeName>
<Initials>PS</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Surgery, 2 Department of Medicine, 3 Department of Radiation Oncology, 4 Department of Radiology, Pancreatic Cancer Program, The Medical College of Wisconsin, Milwaukee, WI 53226, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Erickson</LastName>
<ForeName>Beth A</ForeName>
<Initials>BA</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Surgery, 2 Department of Medicine, 3 Department of Radiation Oncology, 4 Department of Radiology, Pancreatic Cancer Program, The Medical College of Wisconsin, Milwaukee, WI 53226, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tolat</LastName>
<ForeName>Parag</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Surgery, 2 Department of Medicine, 3 Department of Radiation Oncology, 4 Department of Radiology, Pancreatic Cancer Program, The Medical College of Wisconsin, Milwaukee, WI 53226, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Johnston</LastName>
<ForeName>Fabian M</ForeName>
<Initials>FM</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Surgery, 2 Department of Medicine, 3 Department of Radiation Oncology, 4 Department of Radiology, Pancreatic Cancer Program, The Medical College of Wisconsin, Milwaukee, WI 53226, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Evans</LastName>
<ForeName>Douglas B</ForeName>
<Initials>DB</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Surgery, 2 Department of Medicine, 3 Department of Radiation Oncology, 4 Department of Radiology, Pancreatic Cancer Program, The Medical College of Wisconsin, Milwaukee, WI 53226, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tsai</LastName>
<ForeName>Susan</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Surgery, 2 Department of Medicine, 3 Department of Radiation Oncology, 4 Department of Radiology, Pancreatic Cancer Program, The Medical College of Wisconsin, Milwaukee, WI 53226, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>China</Country>
<MedlineTA>J Gastrointest Oncol</MedlineTA>
<NlmUniqueID>101557751</NlmUniqueID>
<ISSNLinking>2078-6891</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Pancreatic cancer (PC)</Keyword>
<Keyword MajorTopicYN="N">neoadjuvant therapy</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2015</Year>
<Month>04</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2015</Year>
<Month>04</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2015</Year>
<Month>8</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2015</Year>
<Month>8</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2015</Year>
<Month>8</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">26261728</ArticleId>
<ArticleId IdType="doi">10.3978/j.issn.2078-6891.2015.053</ArticleId>
<ArticleId IdType="pii">jgo-06-04-418</ArticleId>
<ArticleId IdType="pmc">PMC4502155</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Gastrointest Endosc. 2012 Jul;76(1):67-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22483859</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2007 Jan 17;297(3):267-77</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17227978</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncologist. 2014 Mar;19(3):266-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24569947</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>HPB (Oxford). 2015 Oct;17 (10 ):942-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26255895</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Surg Oncol. 2014 Sep;21(9):2873-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24770680</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Chemother Pharmacol. 2008 Jan;61(1):167-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17440727</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Surg. 2012 Aug;147(8):753-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22911074</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2011 May 12;364(19):1817-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21561347</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Surg. 2015 Jan;261(1):12-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25599322</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gastrointest Surg. 2015 Jan;19(1):80-6; discussion 86-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25091851</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Coll Surg. 2014 Mar;218(3):401-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24484730</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gastrointest Surg. 2006 Dec;10(10):1371-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17175456</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 2014 Jun 1;74(11):2913-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24840647</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Surg. 1999 Dec;230(6):776-82; discussion 782-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10615932</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Oncol. 2009 Apr 10;27(11):1806-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19273710</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Surg Oncol. 2009 Jul;16(7):1736-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19387741</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Natl Cancer Inst. 2014 Mar;106(3):dju011</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24563516</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Surg. 1993 Feb;217(2):144-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8094952</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Oncol. 2008 Jul 20;26(21):3496-502</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18640930</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Surg Oncol Clin N Am. 2004 Oct;13(4):639-61, ix</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15350939</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gastrointest Surg. 2005 Nov;9(8):1094-104; discussion 1104-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16269380</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Surgery. 2011 Sep;150(3):547-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21621236</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Surg Oncol. 2014 Dec;21(13):4351-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25092157</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Coll Surg. 2012 Jan;214(1):33-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22055585</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Coll Surg. 1998 Jun;186(6):675-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9632157</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Oncol. 2008 Jul 20;26(21):3487-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18640929</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer. 2013 Aug 1;119(15):2692-700</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23720019</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2010 Sep 8;304(10):1073-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20823433</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Surg Oncol. 2006 Aug;13(8):1035-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16865597</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Surg Oncol. 2012 Jan;19(1):169-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21761104</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer J. 2012 Nov-Dec;18(6):511-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23187837</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Surg Oncol. 2010 Jul;17(7):1794-801</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20162463</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer J. 2012 Nov-Dec;18(6):539-49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23187840</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Surg. 2009 Apr;249(4):682-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19300217</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Oncol. 2010 Aug 1;28(22):3617-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20606091</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pancreas. 2013 Nov;42(8):1311-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24152956</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer. 1999 Mar 15;85(6):1261-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10189130</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Natl Compr Canc Netw. 2010 Sep;8(9):972-1017</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20876541</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer. 1980 Nov 1;46(9):1945-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7427900</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer. 2012 Dec 1;118(23 ):5749-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22605518</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Oncol. 2005 May 20;23(15):3509-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15908661</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Coll Surg. 2008 May;206(5):833-46; discussion 846-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18471707</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Oncol. 2011 Dec 1;29(34):4548-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21969517</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gastrointest Surg. 2014 May;18(5):917-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24347313</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gastrointest Surg. 2014 Feb;18(2):269-78; discussion 278</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24129826</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2004 Mar 18;350(12):1200-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15028824</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2014 Jan 30;370(5):479-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24476438</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Surg. 1985 Aug;120(8):899-903</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">4015380</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Surg. 2015 Mar;261(3):432-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24887971</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Surg. 1992 Nov;127(11):1335-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1359851</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Surg. 2009 Sep;250(3):449-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19730176</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>